H.A. Verbrugh
- Epidemiology
- Infectious Diseases top 10%
- Pharmacology top 10%
- Molecular Biology
- Urology top 5%
- Co-authors
- R P VerkooyenPhillip K. PetersonW N M HustinxP LeguitPeter J. de VriesR. PetersA.J. Mintjes-de GrootJ. Verhoef
- Topics
- Antimicrobial Resistance in Staphylococcus (8 papers)Antibiotic Use and Resistance (5 papers)Bacterial Identification and Susceptibility Testing (4 papers)
- Partner nations
- NetherlandsUnited StatesIndonesia
In The Last Decade
H.A. Verbrugh
20 papers receiving 412 citations
Peers
Comparison fields: 5 of 81
- Epidemiology 183
- Infectious Diseases 165
- Pharmacology 95
- Molecular Biology 69
- Urology 64
Countries citing papers authored by H.A. Verbrugh
This map shows the geographic impact of H.A. Verbrugh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.A. Verbrugh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.A. Verbrugh more than expected).
Fields of papers citing papers by H.A. Verbrugh
This network shows the impact of papers produced by H.A. Verbrugh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.A. Verbrugh. The network helps show where H.A. Verbrugh may publish in the future.
Co-authorship network of co-authors of H.A. Verbrugh
This figure shows the co-authorship network connecting the top 25 collaborators of H.A. Verbrugh. A scholar is included among the top collaborators of H.A. Verbrugh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.A. Verbrugh. H.A. Verbrugh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 5 years of experience implementing a methicillin-resistant Staphylococcus aureus search and destroy policy at the largest university medical center in the Netherlands | 4 |
| 3 | [Antibiotic resistance: epidemiological developments and preventive measures]. | 5 |
| 4 | Staphylococcus aureus carriage patterns and the risk of infections associated with continuous peritoneal dialysis. | 1 |
| 5 | Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults. | 4 |
| 6 | Human factor in Staphylococcus aureus nasal carriage | 4 |
| 7 | 20 | |
| 8 | Antimicrobial resistance in Indonesia: prevalence and prevention | 9 |
| 9 | 23 | |
| 10 | 72 | |
| 11 | 39 | |
| 12 | 45 | |
| 13 | [Registration and prevention of hospital infections in a general hospital]. | 3 |
| 14 | 64 | |
| 15 | The effect of dwell time on peritoneal phagocytic defense of chronic peritoneal dialysis patients. | 8 |
| 16 | 20 | |
| 17 | 1 | |
| 18 | 17 | |
| 19 | 43 | |
| 20 | 73 |
About H.A. Verbrugh
H.A. Verbrugh is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases and Clinical Biochemistry, having authored 20 papers that have together received 458 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (8 papers), Antibiotic Use and Resistance (5 papers) and Bacterial Identification and Susceptibility Testing (4 papers). The work is most often cited by research in Molecular Medicine (52 citations), Urology (64 citations) and Clinical Biochemistry (63 citations). H.A. Verbrugh has collaborated with scholars based in Netherlands, United States and Indonesia. Frequent co-authors include R P Verkooyen, Phillip K. Peterson, W N M Hustinx, P Leguit, Peter J. de Vries, R. Peters, A.J. Mintjes-de Groot, J. Verhoef, Inez-Anne Haagen and Arie P.J. van Dijk. Their work appears in journals such as The Lancet, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.